During the morning session, local factors that serve to promote or interfere with cell survival will be discussed, followed by a detailed review of cell types under active investigation. This will be followed by a review of cell delivery strategies and methods for evaluating their effects. An open debate over lunch will follow. The afternoon session will consist of a comprehensive review of data from both completed and ongoing clinical trials for both acute and chronic myocardial disease, followed by a question-and-answer session.
The Symposium will bring together the leaders in the field of cardiac myogenesis. It is anticipated that many attendees will have preexisting knowledge of principles, experimental design, and results of completed studies in the field of cell therapy for cardiovascular diseases. A wide cross-section of members of basic and clinical researchers, from academic, industry, and regulatory communities will be in attendance.
Wednesday, June 16, 2004
8:00 a.m. to 5:00 p.m.
New York Academy of Medicine
1216 Fifth Avenue
Corner of Fifth Avenue and 103rd Street
New York, NY 10029
Warren Sherman, M.D.
Director of Medical Education, Cardiac Catheterization Laboratories
Associate Director, Cardiac Catheterization Laboratories
The Zena and Michael A. Wiener Cardiovascular Institute
The Mount Sinai Hospital, New York
Valentin Fuster, M.D., Ph.D.
Director, The Zena and Michael A. Wiener Cardiovascular Institute and The M
Contact: Mount Sinai Press Office
The Mount Sinai Hospital / Mount Sinai School of Medicine